Literature DB >> 30788902

Identification of symbol digit modality test score extremes in Huntington's disease.

Ulrike Braisch1, Rainer Muche1, Dietrich Rothenbacher1, Georg Bernhard Landwehrmeyer2, Jeffrey D Long3,4, Michael Orth2.   

Abstract

Studying individuals with extreme phenotypes could facilitate the understanding of disease modification by genetic or environmental factors. Our aim was to identify Huntington's disease (HD) patients with extreme symbol digit modality test (SDMT) scores. We first examined in HD the contribution of cognitive measures of the Unified Huntington's Disease Rating Scale (UHDRS) in predicting clinical endpoints. The language-independent SDMT was used to identify patients performing very well or very poorly relative to their CAG and age cohort. We used data from REGISTRY and COHORT observational study participants (5,603 HD participants with CAG repeats above 39 with 13,868 visits) and of 1,006 healthy volunteers (with 2,241 visits), included to identify natural aging and education effects on cognitive measures. Separate Cox proportional hazards models with CAG, age at study entry, education, sex, UHDRS total motor score and cognitive (SDMT, verbal fluency, Stroop tests) scores as covariates were used to predict clinical endpoints. Quantile regression for longitudinal language-independent SDMT data was used for boundary (2.5% and 97.5% quantiles) estimation and extreme score analyses stratified by age, education, and CAG repeat length. Ten percent of HD participants had an extreme SDMT phenotype for at least one visit. In contrast, only about 3% of participants were consistent SDMT extremes at two or more visits. The thresholds for the one-visit and two-visit extremes can be used to classify existing and new individuals. The identification of these phenotype extremes can be useful in the search for disease modifiers.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  COHORT; Cox hazard model; REGISTRY; quantile regression; symbol digit modalities test

Mesh:

Year:  2019        PMID: 30788902     DOI: 10.1002/ajmg.b.32719

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  3 in total

1.  Genetic modifiers of Huntington disease differentially influence motor and cognitive domains.

Authors:  Jong-Min Lee; Yuan Huang; Michael Orth; Tammy Gillis; Jacqueline Siciliano; Eunpyo Hong; Jayalakshmi Srinidhi Mysore; Diane Lucente; Vanessa C Wheeler; Ihn Sik Seong; Zachariah L McLean; James A Mills; Branduff McAllister; Sergey V Lobanov; Thomas H Massey; Marc Ciosi; G Bernhard Landwehrmeyer; Jane S Paulsen; E Ray Dorsey; Ira Shoulson; Cristina Sampaio; Darren G Monckton; Seung Kwak; Peter Holmans; Lesley Jones; Marcy E MacDonald; Jeffrey D Long; James F Gusella
Journal:  Am J Hum Genet       Date:  2022-03-23       Impact factor: 11.043

2.  Structural brain correlates of dementia in Huntington's disease.

Authors:  Saul Martinez-Horta; Frederic Sampedro; Andrea Horta-Barba; Jesús Perez-Perez; Javier Pagonabarraga; Beatriz Gomez-Anson; Jaime Kulisevsky
Journal:  Neuroimage Clin       Date:  2020-09-09       Impact factor: 4.881

Review 3.  Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations.

Authors:  Sukriti Vishwas; Monica Gulati; Bhupinder Kapoor; Saurabh Gupta; Sachin Kumar Singh; Ankit Awasthi; Arzoo Khan; Aditya Goyal; Anil Bansal; Suman Baishnab; Thakur Gurjeet Singh; Sandeep Arora; Omji Porwal; Ankit Kumar; Vijay Kumar
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.